Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...

Kimberly-Clark, which owns Huggies and Kleenex, is acquiring Kenvue, the maker of Tylenol, in a cash and stock deal worth ...

Researchers pinpointed an association between maternal covid-19 infections and children being diagnosed with ...

Health and Human Services Secretary Robert F. Kennedy Jr. further added to the Trump administration’s problematic claims about Tylenol and autism on Oct. 9, alleging during a Cabinet meeting that ...

Health Secretary Robert F. Kennedy Jr. suggested there may be a link between autism and circumcision while reasserting the unproven theory that Tylenol causes the disorder — and medical experts are ...

Doctors say misinformation is spreading about Tylenol online. Since President Donald Trump announced at a White House news conference three weeks ago that pregnant women's use of Tylenol might raise ...

ATLANTA (WJBF) — Reaction is pouring in from medical experts and federal agencies after recent claims connecting Tylenol use during pregnancy to a higher risk of autism and ADHD. Last month, President ...